T45 Labs

About T45 Labs

T45 Labs is a specialized medical technology innovation company based in Santa Clara, Silicon Valley, California. They focus on developing minimally invasive technologies to address large unmet clinical needs in the cardiovascular space, utilizing a fast-follower strategy to bring breakthrough medical technologies to market quickly with minimized risk.

Products & Services

Advanced NanoTherapies (ANT):Pioneering a dual-drug-coated balloon (DCB) platform to treat de novo coronary lesions, peripheral artery disease, and coronary in-stent restenosis using a nanoparticle system with sirolimus and paclitaxel.

VahatiCor:Focused on addressing Coronary Microvascular Dysfunction (CMD) with an innovative implantable device to improve microvascular perfusion in patients who have exhausted traditional therapies.

NuevoSono:Developing technology for near OCT resolution imaging with HD-IVUS depth, providing a plug-n-play system for visualizing coronary, peripheral, and venous anatomies.

Specialties

Minimally invasive technologies Cardiovascular medical devices Fast-follower strategy Breakthrough medical technology development

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Fund I T: - FT: Fund I	A: 25000000 MR: - FA: $25 million FAN: 25000000	D: 2025-03-19 FD: 2025-03-19	-

Fund I Latest

2025-03-19

$25.0M

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

R

Rishi Puri

Lead Medical Director

M

Marwan Berrada-Sounni

Founder and Managing Partner

Recent News

T45 Labs Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised